[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] #  @Hall8Jack Jack Hall Jack Hall posts on X about $srpt, $arwr, $rna, $pepg the most. They currently have XXXXX followers and XXX posts still getting attention that total XX engagements in the last XX hours. ### Engagements: XX [#](/creator/twitter::2598246906/interactions)  - X Week XXXXX -XX% - X Month XXXXXX +17% - X Months XXXXXXX -XXXX% - X Year XXXXXXX +86% ### Mentions: X [#](/creator/twitter::2598246906/posts_active)  - X Week XX -XX% - X Month XX -XX% - X Months XXX -XX% - X Year XXX +173% ### Followers: XXXXX [#](/creator/twitter::2598246906/followers)  - X Week XXXXX +0.19% - X Month XXXXX +1.30% - X Months XXXXX +9.10% - X Year XXXXX -XXXX% ### CreatorRank: undefined [#](/creator/twitter::2598246906/influencer_rank)  ### Social Influence [#](/creator/twitter::2598246906/influence) --- **Social category influence** [stocks](/list/stocks) XXXX% [finance](/list/finance) XXXX% **Social topic influence** [$srpt](/topic/$srpt) #28, [$arwr](/topic/$arwr) #6, [$rna](/topic/$rna) 3.33%, [$pepg](/topic/$pepg) 3.33%, [$dyn](/topic/$dyn) 2.5%, [$wve](/topic/$wve) 1.67%, [dyn](/topic/dyn) 1.67%, [$qure](/topic/$qure) 1.67%, [summary](/topic/summary) 0.83%, [grind](/topic/grind) XXXX% **Top accounts mentioned or mentioned by** [@ttramyloid](/creator/undefined) [@jfais20](/creator/undefined) [@yachmod](/creator/undefined) [@sanctuarybio](/creator/undefined) [@rnaianalyst](/creator/undefined) [@bionerd51](/creator/undefined) [@jonu235](/creator/undefined) [@charle77238](/creator/undefined) [@surferbackpack](/creator/undefined) [@blippd](/creator/undefined) [@financiallies](/creator/undefined) [@edcollins23](/creator/undefined) [@nationwidekids](/creator/undefined) [@mattb79569101](/creator/undefined) [@sharkbiotech](/creator/undefined) [@mauriceontw](/creator/undefined) [@scamsweeper](/creator/undefined) [@paixtrader](/creator/undefined) [@quantumup1](/creator/undefined) [@andreagtc](/creator/undefined) **Top assets mentioned** [Sarepta Therapeutics, Inc. (SRPT)](/topic/$srpt) [Arrowhead Research Corporation (ARWR)](/topic/$arwr) [Avidity Biosciences, Inc. Common Stock (RNA)](/topic/$rna) [Dyne Therapeutics, Inc. Common Stock (DYN)](/topic/$dyn) [uniQure N.V. (QURE)](/topic/$qure) [Ionis Pharmaceuticals, Inc. Common Stock (IONS)](/topic/$ions) [Alnylam Pharmaceuticals, Inc. (ALNY)](/topic/$alny) ### Top Social Posts [#](/creator/twitter::2598246906/posts) --- Top posts by engagements in the last XX hours "@TTRAmyloid (2/2) $rna $srpt $dyn $wve $pepg #NS Exon skip tough from a regulatory standpt in terms of grind it out piecemeal approvals; many skippers have small TAMs (ie exon 44); v crowded in terms of competition. Good summary on DMD exon skipping field/competition:" [X Link](https://x.com/Hall8Jack/status/1963849323847795048) [@Hall8Jack](/creator/x/Hall8Jack) 2025-09-05T06:19Z 1588 followers, XXX engagements "@blippd @scamsweeper (2/2) so safety is in question for their platform and all comes down to MAD. But imo $pepg has a chance as $rna most advanced in DM1 but efficacy+safety pretty mediocre. Also $arwr DM1 data imminent and also has chance at BIC as think theyve gotten well beyond 4mg/kg" [X Link](https://x.com/Hall8Jack/status/1970958571123982676) [@Hall8Jack](/creator/x/Hall8Jack) 2025-09-24T21:08Z 1587 followers, 1062 engagements "@blippd @scamsweeper Also only seen splicing data from $pepg If so really need to see DM1 functional data in MAD $rna $dyn $arwr" [X Link](https://x.com/Hall8Jack/status/1970959415273816419) [@Hall8Jack](/creator/x/Hall8Jack) 2025-09-24T21:11Z 1587 followers, XXX engagements "@Pharmdca If you look at what happened to PGN-EDO51 after it went from sad to mad studies (clinical hold; discontinued) not a big shocker where $pepg market cap is. PGN-EDODM1 about to go from sad to mad. $rna $dyn $arwr $srpt . Also this:" [X Link](https://x.com/Hall8Jack/status/1971234260645470342) [@Hall8Jack](/creator/x/Hall8Jack) 2025-09-25T15:24Z 1587 followers, 1167 engagements "@newerraa Do you have any expectations from the ARO-MMP7 IPF trial $arwr has proven they can get lung exposure with ARO-RAGE but $srpt doesnt mention ARO-MMP7 anymore" [X Link](https://x.com/Hall8Jack/status/1975603842571235671) [@Hall8Jack](/creator/x/Hall8Jack) 2025-10-07T16:47Z 1589 followers, 1056 engagements "@RNAiAnalyst Did you read this AMT-130 apparently lowers both WT and mutant HTT. Very similar to $arwr / $srpt approach. Obviously $qure intrinsically brain targeted but arwr likely has brain targeting advantages (subQ vs IT) over $ions $alny $wve etc. Should be interesting" [X Link](https://x.com/Hall8Jack/status/1976021537317933451) [@Hall8Jack](/creator/x/Hall8Jack) 2025-10-08T20:27Z 1588 followers, 1412 engagements "@BiotechAnalysst So thats X Imlifidase studies from $hnsa - one with Genethon and this from $srpt :" [X Link](https://x.com/Hall8Jack/status/1978043576035520753) [@Hall8Jack](/creator/x/Hall8Jack) 2025-10-14T10:21Z 1588 followers, 1415 engagements "@yachmod Think you mean Genethon $srpt used to own US rights to this. Not sure where that stands now:" [X Link](https://x.com/Hall8Jack/status/1976815329713283371) [@Hall8Jack](/creator/x/Hall8Jack) 2025-10-11T01:01Z 1588 followers, XXX engagements "@richtrades100 If you look at recent pps performance and regulatory updates $tsha and $ngne have gotten for their Rett GTx or $qure for their HD GTx- $srpt *should* have very similar path for their LGMD2e GTx" [X Link](https://x.com/Hall8Jack/status/1976817749554086176) [@Hall8Jack](/creator/x/Hall8Jack) 2025-10-11T01:10Z 1588 followers, XXX engagements "$arwr $srpt siRNA IPF trial completed:" [X Link](https://x.com/Hall8Jack/status/1978587074350518780) [@Hall8Jack](/creator/x/Hall8Jack) 2025-10-15T22:21Z 1588 followers, 1674 engagements "@newerraa Interesting $srpt has terminated or withdrawn several trials recently due to business decision (recent restructuring) in LGMDs and Elevidys/plasmapheresis but has not made similar decision in IPF . $arwr " [X Link](https://x.com/Hall8Jack/status/1978669913821643028) [@Hall8Jack](/creator/x/Hall8Jack) 2025-10-16T03:50Z 1587 followers, 1229 engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@Hall8Jack Jack Hall
Jack Hall posts on X about $srpt, $arwr, $rna, $pepg the most. They currently have XXXXX followers and XXX posts still getting attention that total XX engagements in the last XX hours.
Engagements: XX #
- X Week XXXXX -XX%
- X Month XXXXXX +17%
- X Months XXXXXXX -XXXX%
- X Year XXXXXXX +86%
Mentions: X #
- X Week XX -XX%
- X Month XX -XX%
- X Months XXX -XX%
- X Year XXX +173%
Followers: XXXXX #
- X Week XXXXX +0.19%
- X Month XXXXX +1.30%
- X Months XXXXX +9.10%
- X Year XXXXX -XXXX%
CreatorRank: undefined #
Social Influence #
Social category influence stocks XXXX% finance XXXX%
Social topic influence $srpt #28, $arwr #6, $rna 3.33%, $pepg 3.33%, $dyn 2.5%, $wve 1.67%, dyn 1.67%, $qure 1.67%, summary 0.83%, grind XXXX%
Top accounts mentioned or mentioned by @ttramyloid @jfais20 @yachmod @sanctuarybio @rnaianalyst @bionerd51 @jonu235 @charle77238 @surferbackpack @blippd @financiallies @edcollins23 @nationwidekids @mattb79569101 @sharkbiotech @mauriceontw @scamsweeper @paixtrader @quantumup1 @andreagtc
Top assets mentioned Sarepta Therapeutics, Inc. (SRPT) Arrowhead Research Corporation (ARWR) Avidity Biosciences, Inc. Common Stock (RNA) Dyne Therapeutics, Inc. Common Stock (DYN) uniQure N.V. (QURE) Ionis Pharmaceuticals, Inc. Common Stock (IONS) Alnylam Pharmaceuticals, Inc. (ALNY)
Top Social Posts #
Top posts by engagements in the last XX hours
"@TTRAmyloid (2/2) $rna $srpt $dyn $wve $pepg #NS Exon skip tough from a regulatory standpt in terms of grind it out piecemeal approvals; many skippers have small TAMs (ie exon 44); v crowded in terms of competition. Good summary on DMD exon skipping field/competition:"
X Link @Hall8Jack 2025-09-05T06:19Z 1588 followers, XXX engagements
"@blippd @scamsweeper (2/2) so safety is in question for their platform and all comes down to MAD. But imo $pepg has a chance as $rna most advanced in DM1 but efficacy+safety pretty mediocre. Also $arwr DM1 data imminent and also has chance at BIC as think theyve gotten well beyond 4mg/kg"
X Link @Hall8Jack 2025-09-24T21:08Z 1587 followers, 1062 engagements
"@blippd @scamsweeper Also only seen splicing data from $pepg If so really need to see DM1 functional data in MAD $rna $dyn $arwr"
X Link @Hall8Jack 2025-09-24T21:11Z 1587 followers, XXX engagements
"@Pharmdca If you look at what happened to PGN-EDO51 after it went from sad to mad studies (clinical hold; discontinued) not a big shocker where $pepg market cap is. PGN-EDODM1 about to go from sad to mad. $rna $dyn $arwr $srpt . Also this:"
X Link @Hall8Jack 2025-09-25T15:24Z 1587 followers, 1167 engagements
"@newerraa Do you have any expectations from the ARO-MMP7 IPF trial $arwr has proven they can get lung exposure with ARO-RAGE but $srpt doesnt mention ARO-MMP7 anymore"
X Link @Hall8Jack 2025-10-07T16:47Z 1589 followers, 1056 engagements
"@RNAiAnalyst Did you read this AMT-130 apparently lowers both WT and mutant HTT. Very similar to $arwr / $srpt approach. Obviously $qure intrinsically brain targeted but arwr likely has brain targeting advantages (subQ vs IT) over $ions $alny $wve etc. Should be interesting"
X Link @Hall8Jack 2025-10-08T20:27Z 1588 followers, 1412 engagements
"@BiotechAnalysst So thats X Imlifidase studies from $hnsa - one with Genethon and this from $srpt :"
X Link @Hall8Jack 2025-10-14T10:21Z 1588 followers, 1415 engagements
"@yachmod Think you mean Genethon $srpt used to own US rights to this. Not sure where that stands now:"
X Link @Hall8Jack 2025-10-11T01:01Z 1588 followers, XXX engagements
"@richtrades100 If you look at recent pps performance and regulatory updates $tsha and $ngne have gotten for their Rett GTx or $qure for their HD GTx- $srpt should have very similar path for their LGMD2e GTx"
X Link @Hall8Jack 2025-10-11T01:10Z 1588 followers, XXX engagements
"$arwr $srpt siRNA IPF trial completed:"
X Link @Hall8Jack 2025-10-15T22:21Z 1588 followers, 1674 engagements
"@newerraa Interesting $srpt has terminated or withdrawn several trials recently due to business decision (recent restructuring) in LGMDs and Elevidys/plasmapheresis but has not made similar decision in IPF . $arwr "
X Link @Hall8Jack 2025-10-16T03:50Z 1587 followers, 1229 engagements